Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
Pricesmart
PSMT
$5.46B
| $321K | ﹤0.01% |
2,785
-366
| -12% | -$41.2K |
|
|
ALX
4452
Alexander's
ALX
$1.41B
| $320K | ﹤0.01% |
969
+68
| +8% | +$21.3K |
|
4453
Scorpio Tankers
STNG
$3.81B
| $320K | ﹤0.01% |
+2,907
| New | +$326K |
|
|
HSH
4454
CALL
DELISTED
HILLSHIRE BRANDS CO
HSH
| $320K | ﹤0.01% |
9,700
-10,000
| -51% | -$325K |
|
|
OREX
4455
CALL
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $320K | ﹤0.01% |
6,400
-7,040
| -52% | -$396K |
|
4456
MKS Inc
MKSI
$20.6B
| $318K | ﹤0.01% |
10,972
-18,625
| -63% | -$542K |
|
|
SVU
4457
CALL
DELISTED
SUPERVALU Inc.
SVU
| $317K | ﹤0.01% |
6,471
-8,172
| -56% | -$403K |
|
4458
Landstar System
LSTR
$6.21B
| $316K | ﹤0.01% |
5,555
-1,283
| -19% | -$71.8K |
|
4459
Invesco Municipal Trust
VKQ
$551M
| $316K | ﹤0.01% |
28,746
+13,775
| +92% | +$158K |
|
|
IPXL
4460
DELISTED
Impax Laboratories, Inc.
IPXL
| $316K | ﹤0.01% |
12,616
-25,099
| -67% | -$560K |
|
4461
CALL
iShares MSCI Taiwan ETF
EWT
$10.7B
| $315K | ﹤0.01% |
11,250
+2,800
| +33% | +$79.8K |
|
4462
W&T Offshore
WTI
$518M
| $315K | ﹤0.01% |
19,666
-44,477
| -69% | -$795K |
|
4463
Groupon
GRPN
$1.02B
| $314K | ﹤0.01% |
1,431
-18,654
| -93% | -$3.85M |
|
4464
Scholastic
SCHL
$792M
| $314K | ﹤0.01% |
9,218
-4,782
| -34% | -$141K |
|
|
MQT
4465
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $313K | ﹤0.01% |
28,436
+8,632
| +44% | +$102K |
|
4466
Westamerica Bancorp
WABC
$1.37B
| $313K | ﹤0.01% |
5,581
-896
| -14% | -$47.8K |
|
4467
Employers Holdings
EIG
$889M
| $312K | ﹤0.01% |
10,061
-10,210
| -50% | -$316K |
|
4468
KB Financial Group
KB
$43.5B
| $312K | ﹤0.01% |
7,795
+961
| +14% | +$36.2K |
|
4469
Unitil
UTL
$980M
| $312K | ﹤0.01% |
10,401
+3,224
| +45% | +$97.1K |
|
|
BBOX
4470
DELISTED
Black Box Corp
BBOX
| $312K | ﹤0.01% |
10,749
-1,109
| -9% | -$30.9K |
|
4471
PUT
Sempra
SRE
$54.8B
| $311K | ﹤0.01% |
7,000
-6,800
| -49% | -$302K |
|
|
MNTA
4472
PUT
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $311K | ﹤0.01% |
18,300
-20,100
| -52% | -$338K |
|
|
BRLI
4473
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $311K | ﹤0.01% |
12,424
-318
| -2% | -$9.8K |
|
|
FNSR
4474
PUT
DELISTED
Finisar Corp
FNSR
| $311K | ﹤0.01% |
13,500
-7,400
| -35% | -$169K |
|
4475
PUT
DTE Energy
DTE
$29.1B
| $310K | ﹤0.01% |
5,523
-940
| -15% | -$53.9K |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.87B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.